Indonesian Tobacco Production Plummets to the Second Lowest Level in Past 6 Years

Market by 2FIRSTS.ai
May.24.2024
Indonesian Tobacco Production Plummets to the Second Lowest Level in Past 6 Years
According to CNBCIndonesia on May 23, Indonesia's tobacco production in April 2024 decreased due to the Lebaran holiday season.

According to CNBC Indonesia on May 23rd, Indonesia saw a decrease in tobacco production in April 2024, which is consistent with the seasonal pattern of Lebaran.

 

According to data from the Ministry of Finance and the General Administration of Customs, the tobacco production in April 2024 reached 19.84 billion cigarettes, a decrease of 28.8% compared to March 2024 (month-on-month). However, when compared to the same period last year (year-on-year), production this year increased by 1.6%.

 

It is worth noting that in April 2024, there will be a long holiday including Idul Fitri, totaling eight days from April 8th to 15th. Due to the increase in holidays, production levels will naturally decrease. Based on historical experience, tobacco production always experiences a decline in months with long holidays. Manufacturers typically ramp up production before the Idul Fitri holiday to meet high demand and prevent a decrease in production during the holiday.

 

According to reports, from 2017 to 2019, the months of the Lebaran holiday, which is before the outbreak of the pandemic, saw a decrease in tobacco production. Overall, the tobacco production from January to April reached 91.34 billion cigarettes. This number is the second lowest level in the past six years. The tobacco production from January to April 2024 is only slightly better than the same period in 2023, but it is significantly lower compared to the production in 2022 of 104.86 billion cigarettes, 101.41 billion cigarettes in 2021, 108.5 billion cigarettes in 2020, 110.9 billion cigarettes in 2019, and 96.72 billion cigarettes in 2018.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
JT Launches Ploom AURA “Navy Blue” Edition with a Limited-Time Half-Price Offer
JT Launches Ploom AURA “Navy Blue” Edition with a Limited-Time Half-Price Offer
From Oct 14, JT will sell the Ploom AURA “Navy Blue” nationwide at convenience stores and select tobacco retailers; the starter kit will be ¥1,480 (down from ¥2,980) from Oct 13–Nov 9.
Oct.09
2Firsts Research | ZYN Launches Limited-Edition Coffee Flavours and Can Engraving Service at Stockholm Arlanda Airport
2Firsts Research | ZYN Launches Limited-Edition Coffee Flavours and Can Engraving Service at Stockholm Arlanda Airport
2Firsts observed that ZYN has introduced limited-edition coffee flavours and an on-site can engraving service in the duty-free zone at Stockholm Arlanda Airport, alongside the rollout of its upgraded packaging and independent core-shelf displays, forming a complete product presentation and consumer experience system.
Nov.17 by 2FIRSTS.ai
Lao Shuts Down Nearly 300 Online Vape Stores in Joint Crackdown with WHO and Meta
Lao Shuts Down Nearly 300 Online Vape Stores in Joint Crackdown with WHO and Meta
In a coordinated effort with the World Health Organization (WHO) and Meta, the Lao Ministry of Health has taken 288 online e-cigarette stores with more than 759,599 members offline, reinforcing the country’s total ban on e-cigarettes under the National Tobacco Control Law.
Nov.20 by 2FIRSTS.ai
The Mexican president has submitted a reform proposal to Congress, proposing a complete ban on e-cigarettes and vaporizers
The Mexican president has submitted a reform proposal to Congress, proposing a complete ban on e-cigarettes and vaporizers
Mexican President Claudia Sheinbaum Pardo submitted a proposal to reform the General Health Law to the President of the House of Representatives, Kenia López Rabadán. The core content of the proposal is to ban e-cigarettes, vaporizers, and similar devices to protect public health. In early 2025, a congressional standing committee confirmed the constitutional validity of the health reform.
Sep.28
Elf Bar Parent iMiracle to Pull Flavored Vapes From California, Ending Altria Unit NJOY Lawsuit
Elf Bar Parent iMiracle to Pull Flavored Vapes From California, Ending Altria Unit NJOY Lawsuit
China’s e-cigarette maker iMiracle, parent company of the Elf Bar brand, has agreed to halt sales of all flavored vaping products in California as part of a settlement with Altria Group’s e-cigarette unit, NJOY LLC, marking the end of a nearly two-year legal dispute.
Oct.13